Learnings from Throwing Paint at the Wall for COVID-19 with an SGLT2 Inhibitor.
Publication Title
Clin J Am Soc Nephrol
Document Type
Article
Publication Date
5-1-2022
Keywords
washington; spokane; covid-19; COVID-19; GFR; SARS-CoV-2; SGLT2; acute kidney injury; dapagliflozin; pandemic; safety; sodium-glucose cotransporter 2; Benzhydryl Compounds; COVID-19; Glucosides; Humans; Kidney; Paint; Sodium-Glucose Transporter 2 Inhibitors
Clinical Institute
Kidney & Diabetes
Specialty/Research Institute
Nephrology
Specialty/Research Institute
Infectious Diseases
Specialty/Research Institute
Endocrinology
COinS
